These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 20387188)
1. Prevalence of Epstein-Barr virus reactivation in pregnancy. Haeri S; Baker AM; Boggess KA Am J Perinatol; 2010 Oct; 27(9):715-9. PubMed ID: 20387188 [TBL] [Abstract][Full Text] [Related]
2. Maternal depression and Epstein-Barr virus reactivation in early pregnancy. Haeri S; Johnson N; Baker AM; Stuebe AM; Raines C; Barrow DA; Boggess KA Obstet Gynecol; 2011 Apr; 117(4):862-866. PubMed ID: 21422857 [TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus infection during pregnancy and the risk of adverse pregnancy outcome. Eskild A; Bruu AL; Stray-Pedersen B; Jenum P BJOG; 2005 Dec; 112(12):1620-4. PubMed ID: 16305564 [TBL] [Abstract][Full Text] [Related]
4. High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies. Chen CJ; Lin KH; Lin SC; Tsai WC; Yen JH; Chang SJ; Lu SN; Liu HW J Rheumatol; 2005 Jan; 32(1):44-7. PubMed ID: 15630723 [TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus in pediatric patients after renal transplantation. Schwab M; Böswald M; Korn K; Ruder H Clin Nephrol; 2000 Feb; 53(2):132-9. PubMed ID: 10711415 [TBL] [Abstract][Full Text] [Related]
7. No risk of maternal EBV infection for childhood leukemia. Tedeschi R; Luostarinen T; Marus A; Bzhalava D; Ogmundsdottir HM; Dillner J; De Paoli P; Surcel HM; Pukkala E; Lehtinen M; Lehtinen T Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2790-2. PubMed ID: 19755652 [TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus reactivation during pregnancy and postpartum: effects of race and racial discrimination. Christian LM; Iams JD; Porter K; Glaser R Brain Behav Immun; 2012 Nov; 26(8):1280-7. PubMed ID: 22940537 [TBL] [Abstract][Full Text] [Related]
9. Activation of maternal Epstein-Barr virus infection and risk of acute leukemia in the offspring. Tedeschi R; Bloigu A; Ogmundsdottir HM; Marus A; Dillner J; dePaoli P; Gudnadottir M; Koskela P; Pukkala E; Lehtinen T; Lehtinen M Am J Epidemiol; 2007 Jan; 165(2):134-7. PubMed ID: 17005627 [TBL] [Abstract][Full Text] [Related]
10. Hypothesis: could Epstein-Barr virus play a role in the development of gastroschisis? Werler MM Birth Defects Res A Clin Mol Teratol; 2010 Feb; 88(2):71-5. PubMed ID: 19937602 [TBL] [Abstract][Full Text] [Related]
11. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription. Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040 [TBL] [Abstract][Full Text] [Related]
12. Unilateral laterothoracic exanthema with coincident evidence of Epstein Barr virus reactivation: exploration of a possible link. Scheinfeld N Dermatol Online J; 2007 Jul; 13(3):13. PubMed ID: 18328207 [TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART. O'Sullivan CE; Peng R; Cole KS; Montelaro RC; Sturgeon T; Jenson HB; Ling PD J Med Virol; 2002 Jul; 67(3):320-6. PubMed ID: 12116021 [TBL] [Abstract][Full Text] [Related]
15. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases. Niller HH; Wolf H; Minarovits J Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410 [TBL] [Abstract][Full Text] [Related]
16. [Epstein-Barr virus infection in patients after bone marrow and heart transplantation]. Zawilińska B; Gruszka K; Piatkowska-Jakubas B; Garlicki M; Skotnicki A Przegl Epidemiol; 2001; 55 Suppl 3():52-5. PubMed ID: 11984959 [TBL] [Abstract][Full Text] [Related]
17. Serum IgA antibodies to Epstein-Barr virus (EBV) early lytic antigens are present in primary EBV infection. Bhaduri-McIntosh S; Landry ML; Nikiforow S; Rotenberg M; El-Guindy A; Miller G J Infect Dis; 2007 Feb; 195(4):483-92. PubMed ID: 17230407 [TBL] [Abstract][Full Text] [Related]
18. Quantitative Epstein-Barr virus (EBV) serology in lung transplant recipients with primary EBV infection and/or post-transplant lymphoproliferative disease. Verschuuren E; van der Bij W; de Boer W; Timens W; Middeldorp J; The TH J Med Virol; 2003 Feb; 69(2):258-66. PubMed ID: 12683416 [TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus-Epstein-Barr virus interaction in patients with AIDS. Challine D; Buisson M; Cadilhac M; Germanidis G; Joab I; Eliaszewicz M; Caumes E; Flahault A; Fillet AM; Pawlotsky JM; Seigneurin JM J Med Virol; 2002 Aug; 67(4):510-5. PubMed ID: 12115996 [TBL] [Abstract][Full Text] [Related]
20. Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome. Seishima M; Yamanaka S; Fujisawa T; Tohyama M; Hashimoto K Br J Dermatol; 2006 Aug; 155(2):344-9. PubMed ID: 16882173 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]